Tesfaye Gelanew

734 total citations
24 papers, 502 citations indexed

About

Tesfaye Gelanew is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Tesfaye Gelanew has authored 24 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Public Health, Environmental and Occupational Health and 11 papers in Epidemiology. Recurrent topics in Tesfaye Gelanew's work include Research on Leishmaniasis Studies (9 papers), Trypanosoma species research and implications (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Tesfaye Gelanew is often cited by papers focused on Research on Leishmaniasis Studies (9 papers), Trypanosoma species research and implications (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Tesfaye Gelanew collaborates with scholars based in Ethiopia, Germany and United States. Tesfaye Gelanew's co-authors include Asrat Hailu, Edoardo Pozio, Marco Lalle, Simone M. Cacciò, Gabriele Schönian, Katrin Kuhls, Elizabeth Hunsperger, Tamrat Abebe, Aysheshm Kassahun and Zewdu Hurissa and has published in prestigious journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tesfaye Gelanew

20 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tesfaye Gelanew Ethiopia	12	246	240	212	171	22	24	502
Silvia Stefánia Longoni Italy	14	150 0.6×	182 0.8×	93 0.4×	158 0.9×	35 1.6×	33	364
Romain Blaizot French Guiana	12	69 0.3×	150 0.6×	158 0.7×	208 1.2×	8 0.4×	60	402
Kathleen A. Rogers United States	10	193 0.8×	158 0.7×	154 0.7×	111 0.6×	4 0.2×	11	371
Françoise Faraut France	13	234 1.0×	699 2.9×	85 0.4×	436 2.5×	11 0.5×	13	804
Clara Muñoz Spain	13	146 0.6×	282 1.2×	163 0.8×	159 0.9×	12 0.5×	37	433
Franklyn Samudio Panama	15	206 0.8×	344 1.4×	132 0.6×	283 1.7×	16 0.7×	28	546
Zabih Zarei Iran	8	196 0.8×	423 1.8×	69 0.3×	229 1.3×	7 0.3×	16	495
Reza Shafiei Iran	13	204 0.8×	127 0.5×	46 0.2×	124 0.7×	77 3.5×	31	399
H W Ghalib Sudan	11	259 1.1×	798 3.3×	53 0.3×	522 3.1×	22 1.0×	13	871
Eugenia Alvarez Peru	9	156 0.6×	505 2.1×	81 0.4×	250 1.5×	11 0.5×	11	590

Countries citing papers authored by Tesfaye Gelanew

Since Specialization

Citations

This map shows the geographic impact of Tesfaye Gelanew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tesfaye Gelanew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tesfaye Gelanew more than expected).

Fields of papers citing papers by Tesfaye Gelanew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tesfaye Gelanew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tesfaye Gelanew. The network helps show where Tesfaye Gelanew may publish in the future.

Co-authorship network of co-authors of Tesfaye Gelanew

This figure shows the co-authorship network connecting the top 25 collaborators of Tesfaye Gelanew. A scholar is included among the top collaborators of Tesfaye Gelanew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tesfaye Gelanew. Tesfaye Gelanew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haile‐Mariam, Tenagne, Tesfaye Gelanew, Michael J. Brennan, et al.. (2025). Integrating genomic, transcriptomic, and phenotypic information to explore drug resistance in Mycobacterium tuberculosis sub-lineage 4.2.2.2. Journal of Applied Microbiology. 136(3).

Haile‐Mariam, Tenagne, Tesfaye Gelanew, Workineh Shibeshi, et al.. (2025). Comparative growth kinetics and drug susceptibility of Mycobacterium tuberculosis lineages prevalent in Ethiopia: implications for tuberculosis treatment and management. Frontiers in Microbiology. 15. 1512580–1512580.

Gudina, Esayas Kebede, Tizta Tilahun, Tsinuel Girma, et al.. (2025). Comparative evaluation of in-house ELISA and two commercial serological assays for the detection of antibodies against SARS-CoV-2. Scientific Reports. 15(1). 13853–13853. 1 indexed citations

Gumi, Balako, et al.. (2024). Seroprevalence of SARS-CoV-2 and Hepatitis B Virus Coinfections among Ethiopians with Acute Leukemia. Cancers. 16(8). 1606–1606. 1 indexed citations

Gelanew, Tesfaye, et al.. (2023). Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?. Frontiers in Public Health. 10. 1046546–1046546.

Gudina, Esayas Kebede, Daniel Yilma, Tsinuel Girma, et al.. (2023). Escalating spread of SARS-CoV-2 infection after school reopening among students in hotspot districts of Oromia Region in Ethiopia: Longitudinal study. PLoS ONE. 18(2). e0280801–e0280801. 1 indexed citations

Merid, Yared, et al.. (2023). SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia. Frontiers in Immunology. 14. 1163688–1163688. 1 indexed citations

Gelanew, Tesfaye, Andargachew Mulu, Markos Abebe, et al.. (2022). A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers. Vaccines. 10(6). 859–859. 10 indexed citations

Zeru, Tàye, et al.. (2021). Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21–49 years in Amhara region, Northern Ethiopia. PLoS ONE. 16(3). e0248949–e0248949. 23 indexed citations

10.

Gelanew, Tesfaye & Elizabeth Hunsperger. (2018). Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1). Virology Journal. 15(1). 10 indexed citations

11.

Sghaier, R.M., Tesfaye Gelanew, Carola Schweynoch, et al.. (2016). Genetic micro-heterogeneity of Leishmania major in emerging foci of zoonotic cutaneous leishmaniasis in Tunisia. Infection Genetics and Evolution. 43. 179–185. 8 indexed citations

12.

Gelanew, Tesfaye, B. Katherine Poole‐Smith, & Elizabeth Hunsperger. (2015). Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1). Journal of Virological Methods. 222. 214–223. 15 indexed citations

13.

Gelanew, Tesfaye, Asrat Hailu, Gabriele Schönian, et al.. (2014). Multilocus sequence and microsatellite identification of intra-specific hybrids and ancestor-like donors among natural Ethiopian isolates of Leishmania donovani. International Journal for Parasitology. 44(10). 751–757. 25 indexed citations

14.

Gelanew, Tesfaye, Israel Cruz, Katrin Kuhls, et al.. (2011). Multilocus microsatellite typing revealed high genetic variability of Leishmania donovani strains isolated during and after a Kala-azar epidemic in Libo Kemkem district, Northwest Ethiopia. Microbes and Infection. 13(6). 595–601. 12 indexed citations

15.

Zanger, Philipp, et al.. (2011). Successful Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica with Liposomal Amphothericin B in an Immunocompromised Traveler Returning from Eritrea. American Journal of Tropical Medicine and Hygiene. 84(5). 692–694. 26 indexed citations

16.

Gelanew, Tesfaye, Zewdu Hurissa, Ermias Diro, et al.. (2011). Disseminated Cutaneous Leishmaniasis Resembling Post-Kala-Azar Dermal Leishmaniasis Caused by Leishmania donovani in Three Patients Co-Infected with Visceral Leishmaniasis and Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in Ethiopia. American Journal of Tropical Medicine and Hygiene. 84(6). 906–912. 24 indexed citations

17.

Gelanew, Tesfaye, Katrin Kuhls, Zewdu Hurissa, et al.. (2010). Inference of Population Structure of Leishmania donovani Strains Isolated from Different Ethiopian Visceral Leishmaniasis Endemic Areas. PLoS neglected tropical diseases. 4(11). e889–e889. 63 indexed citations

18.

Gelanew, Tesfaye, Wondwossen Amogne, Tamrat Abebe, et al.. (2010). A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy. British Journal of Dermatology. 163(4). 870–874. 16 indexed citations

19.

Gelanew, Tesfaye, Marco Lalle, Asrat Hailu, Edoardo Pozio, & Simone M. Cacciò. (2007). Molecular characterization of human isolates of Giardia duodenalis from Ethiopia. Acta Tropica. 102(2). 92–99. 188 indexed citations

20.

Pozio, Edoardo, Chris Foggin, Tesfaye Gelanew, et al.. (2006). Trichinella zimbabwensis in wild reptiles of Zimbabwe and Mozambique and farmed reptiles of Ethiopia. Veterinary Parasitology. 143(3-4). 305–310. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact